FIELD: medicine.
SUBSTANCE: invention refers to medicine, and concerns a composition for intranasal administration in the form of a supernatant fluid or gel prepared of at least one growth factor-containing blood component for treating a neurodegenerative disease wherein the blood-containing growth factor-containing component is enriched with plasma growth factors.
EFFECT: invention provides treating a neurodegenerative disease.
1 cl, 5 dwg, 1 ex
Authors
Dates
2019-08-02—Published
2013-07-19—Filed